EMERGENT BIOSOLUTIONS INC. (EBS) Share buybacks
- Total buybacks · last 12 months (USD): Value $36.00M; Formula and calculation Trailing-year cash paid for share repurchases. Period ending 2026-06-30..
- Buyback yield · 12 months: Value (m); Formula and calculation Cash paid for share repurchases / current market cap. Period ending 2026-06-30..
Share buybacks
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total buybacks · last 12 months (USD) | $36.00M | Trailing-year cash paid for share repurchases. Period ending 2026-06-30. |
| Buyback yield · 12 months | (m) | Cash paid for share repurchases / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Buybacks · 12 months | 36.00M USD | Payments for Repurchase of Common Stock |
| Market cap | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total buybacks | Market cap (USD) | Buyback yield |
|---|---|---|---|
| 2026-06-30 | $36.00M | (m) | (m) |
| 2026-03-31 | $33.90M | (m) | (m) |
| 2025-12-31 | $24.90M | (m) | (m) |
| 2025-09-30 | $15.80M | (m) | (m) |
| 2025-06-30 | $6.90M | (m) | (m) |
| 2025-03-31 | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | (m) | (m) |
| 2024-09-30 | $0.00 | (m) | (m) |
| 2024-06-30 | $0.00 | (m) | (m) |
| 2023-12-31 | $0.00 | (m) | (m) |
| 2023-09-30 | $200.00K | (m) | (m) |
| 2023-06-30 | $200.00K | (m) | (m) |
| 2023-03-31 | $24.60M | (m) | (m) |
| 2022-12-31 | $82.10M | (m) | (m) |
| 2022-09-30 | $187.90M | (m) | (m) |
| 2022-06-30 | $187.90M | (m) | (m) |
| 2022-03-31 | $163.50M | (m) | (m) |
| 2021-12-31 | $106.00M | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) |
| 2020-12-31 | $0.00 | (m) | (m) |
| 2019-12-31 | $0.00 | (m) | (m) |
| 2019-09-30 | $0.00 | (m) | (m) |
| 2019-06-30 | $0.00 | (m) | (m) |
| 2019-03-31 | $0.00 | (m) | (m) |
| 2018-12-31 | $100.00K | (m) | (m) |
| 2018-09-30 | $33.14M | (m) | (m) |
| 2018-06-30 | $33.14M | (m) | (m) |
| 2018-03-31 | $33.14M | (m) | (m) |
| 2017-12-31 | $33.08M | (m) | (m) |
| 2017-09-30 | $83.00K | (m) | (m) |
| 2017-06-30 | $83.00K | (m) | (m) |
| 2017-03-31 | $81.00K | (m) | (m) |
| 2016-12-31 | $0.00 | (m) | (m) |
| 2016-09-30 | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | (m) |
| 2015-12-31 | $100.00K | (m) | (m) |
| 2014-12-31 | $200.00K | (m) | (m) |
| 2013-12-31 | $213.00K | (m) | (m) |
| 2013-09-30 | $4.45M | (m) | (m) |
| 2012-12-31 | $5.91M | (m) | (m) |
| 2012-09-30 | (m) | (m) | (m) |
| 2011-12-31 | $0.00 | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) |
| 2010-12-31 | $0.00 | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |